AIMD — Ainos Share Price
0.000.00%
Last trade - 00:00- $8.33m
- $16.43m
- $0.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.54 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 401.73 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -56.77% | ||
| Return on Equity | -74.38% | ||
| Operating Margin | -68098.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.02 | 0.59 | 3.52 | 0.12 | 0.02 | n/a | n/a | 12.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. Its product pipeline includes VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human and animal drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza and Sjogrens syndrome.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 25th, 1984
- Public Since
- August 8th, 1996
- No. of Shareholders
- 241
- No. of Employees
- 44
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 15,433,257
- Address
- 8880 Rio San Diego Drive, Ste. 800, SAN DIEGO, 92108
- Web
- https://www.ainos.com/
- Phone
- +1 8588692986
- Contact
- Chihheng Lu
- Auditors
- KCCW Accounting Corp
Upcoming Events for AIMD
Q2 2025 Ainos Inc Earnings Release
Ainos Inc Annual Shareholders Meeting
Q3 2025 Ainos Inc Earnings Release
Similar to AIMD
Abeona Therapeutics
NASDAQ Capital Market
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
FAQ
What is the Ainos share price?
As of Today at 19:08 UTC, shares in Ainos are trading at $0.54. This share price information is delayed by 15 minutes.
How has the Ainos share price performed this year?
Shares in Ainos last closed at $0.54 and the price had moved by -49.57% over the past 365 days. In terms of relative price strength the Ainos share price has underperformed the S&P500 Index by -53.47% over the past year.
What are the analyst and broker recommendations for Ainos?
There is no consensus recommendation for this security.
Find out moreWhat is the Ainos dividend yield?
Ainos does not currently pay a dividend.
Does Ainos pay a dividend?
Ainos does not currently pay a dividend.
When does Ainos next pay dividends?
Ainos does not currently pay a dividend.
How do I buy Ainos shares?
To buy shares in Ainos you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ainos?
As of the previous close price of $0.54, shares in Ainos had a market capitalisation of $8.33m.
Where are Ainos shares listed?
Here are the trading details for Ainos:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AIMD
What kind of share is Ainos?
Based on an overall assessment of its quality, value and momentum Ainos is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ainos share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Ainos share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ainos. Over the past six months, its share price has outperformed the S&P500 Index by +19.25%.
As of the last closing price of $0.54, shares in Ainos were trading -1.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ainos PE Ratio?
The Ainos PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ainos?
Ainos' management team is headed by:
- Tsai Chun-Hsien - CHM
- Wu Hui-lan - CFO
- Lawrence Lin - EVP
- John Lee - SEC
- Chih-heng Lu - SEC